Tumor necrosis factor receptor superfamily member 8


  • Accession: P28908
  • Swissprot: TNR8_HUMAN
  • Organism: Homo sapiens
  • Gene: TNFRSF8
  • Target class: Membrane receptor

Drug Relations:

brentuximab vedotin
a CD30-directed antibody-drug conjugate consisting of three components: the chimeric IgG1 antibody cAC10, specific for human CD30, the microtubule disrupting agent MMAE, and a protease-cleavable linker that covalently attaches MMAE to cAC10 Bioactivity details MOA